Generics Market Taking Center Stage in South East Asia

Generics Market Taking Center Stage in South East Asia

KUALA LUMPUR, Malaysia, Aug. 19, 2013 /PRNewswire/ -- The Southeast Asian pharmaceuticals industry is fast taking up centre stage in the region, and continues to gain attention and demand from both patients and governments.  By 2016, the market is forecasted to grow to US$3.9 billion. 

Marcus Pitt, President Director/CEO, SOHO Group, who will be speaking at the upcoming CPhI Generics Southeast Asia Summit 2013, notes that "As the developing economies continue to grow - there appears to be a greater concern of governments to establish greater access to healthcare. This is evidenced in markets such as Indonesia where the government is soon to implement its 'universal health coverage' initiative. This is a huge undertaking by the government who within the next four years has targeted touching on over 90% of the population - a huge undertaking given Indonesia's population of 240 million people. The pharmaceutical market dominated by local players has been gearing up its production and distribution infrastructure to cope with the expected multiple increases in generics. The market still enjoys the categories of branded and unbranded - with price points segmented based on the characteristics of socio economic factors." 

Macroeconomic factors including regional government policies, stable economies, and booming population are driving generics in the region and the pharmaceutical industry are looking leverage the demand. Dr. Jennifer Jian Kang, Senior Patent Attorney of Bayer Healthcare (China) who will also be speaking at the regional Generics Summit also commented that "Generics will grow in the next 5-10 years. But without a balanced environment for cultivating innovation, such development will not be sustainable."  Another speaker, Rhett Hemedes, Head - OTC Marketing of Great Eastern Drug Co. Ltd. also adds, "Access and distribution are closely interlinked and is a fundamental part of our operations.  With a more mobile, digitised and engaged lifestyle, certain channels will emerge with the Asian Economic Community expected to impact in 3 years' time. Partnering with leading organisations in this area needs to be strengthened and understood on a country-centric basis. Various ways of working and cooperation also needs to be considered to ensure that the products are made available where consumers will need the products most."

The CPhI Southeast Asia Summit 2013 will take place in Bangkok from 23 - 25 September. The Summit is a platform for business knowledge sharing and networking amongst top tier government, buyers, distributors, big pharma as well as regional and local manufacturers. It will address macroeconomic factors, policies, issues and drivers affecting the pharmaceutical industry in Southeast Asia with speakers from the Ministry of Health, Malaysia, Food and Drug Administration, Philippines,  SOHO Group, MEGA WeCare, Great Eastern Drug and many more.

For more information about CPhI Generics Southeast Asia Summit 2013, please visit:  http://www.cphigenericssea.com

About CPhI:

CPhI Conferences deliver the latest pharma market insight, in-depth case studies and exceptional networking opportunities through a programme of high-level conferences. The worldwide series of events, spanning four continents, provides the optimum forum for you to learn, make new business connections and identify the latest growth opportunities. 

Delivered by expert teams in each region, every conference is extensively researched with leading professionals, ensuring that CPhI Conferences tackle the most business critical issues facing the pharma industry today.

For more information about CPhI, please visit - www.cphiconferences.com

About the Organiser

UBM is a global live media and B2B communications, marketing service and data provider. We help organisations make connections, communicate their proposition and do business effectively. We enable professional people in more than 40 countries around the world to connect and engage with each other, with the markets they serve and with the information they need to succeed. And we do this by whatever means works best - at live events, through digital media or in publications.

Our 6,500 expert staff are deeply embedded in the many specialist communities we serve, bringing both an unusual depth of understanding and real know-how. We organise hundreds of live events each year; we provide data, marketing and information products; we offer a portfolio of market-leading online and print titles; and we support professional communicators through our targeting, distribution and monitoring services.

Our culture of innovation and collaboration brings our people together around common interests to create value, enhancing our ability to do exactly the same for UBM customers. So, whatever their business and wherever they operate, our customers do better business through us.

For more information about UBM, please visit - http://www.ubm.com

Media Contact:

Marcus Chan
Senior Marketing Associate (ASEAN)
DID : +603-2176-8703
HP : +601-2227-7286
E-mail: [email protected]

SOURCE UBM Conferences (ASEAN)

Web Site: http://www.ubm.com

Suggested Articles

Move over, Roche. There’s a new small-cell lung cancer therapy on the scene, and it belongs to AstraZeneca.

Fujifilm says it is prepared to ramp up production of Avigan for any country that wants to try it as a potential treatment for COVID-19.

Gilead CEO promised to make remdesivir affordable, shortly after the company backed off its request for orphan status amid a public backlash.